BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 32556969)

  • 21. MRGPRX4 in Cholestatic Pruritus.
    Yu H; Wangensteen K; Deng T; Li Y; Luo W
    Semin Liver Dis; 2021 Aug; 41(3):358-367. PubMed ID: 34161994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cholestatic pruritus : new insights into pathophysiology and current treatment].
    Kremer AE; Oude Elferink RP; Beuers U
    Hautarzt; 2012 Jul; 63(7):532-8. PubMed ID: 22733242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naltrexone for cholestatic itch: a systematic review.
    Murray-Brown FL
    BMJ Support Palliat Care; 2021 Jun; 11(2):217-225. PubMed ID: 33692114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholestatic Pruritus Treatments in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Systematic Literature Review.
    Smith HT; de Souza AR; Thompson AH; McLaughlin MM; Dever JJ; Myers JA; Chen JV
    Dig Dis Sci; 2023 Jun; 68(6):2710-2730. PubMed ID: 36933112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seladelpar improved measures of pruritus, sleep, and fatigue and decreased serum bile acids in patients with primary biliary cholangitis.
    Kremer AE; Mayo MJ; Hirschfield G; Levy C; Bowlus CL; Jones DE; Steinberg A; McWherter CA; Choi YJ
    Liver Int; 2022 Jan; 42(1):112-123. PubMed ID: 34403559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum Autotaxin Activity Correlates With Pruritus in Pediatric Cholestatic Disorders.
    Kremer AE; Gonzales E; Schaap FG; Oude Elferink RP; Jacquemin E; Beuers U
    J Pediatr Gastroenterol Nutr; 2016 Apr; 62(4):530-5. PubMed ID: 26628447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Itch Management: Treatments under Development.
    Pereira MP; Ständer S
    Curr Probl Dermatol; 2016; 50():71-6. PubMed ID: 27578074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between pruritus and sleep in participants with primary biliary cholangitis in the Phase 2b GLIMMER trial.
    von Maltzahn R; Mayo MJ; Smith HT; Thompson A; Das S; de Souza AR; Lisi E; Levy C; McLaughlin MM; Jones D
    J Patient Rep Outcomes; 2024 Jun; 8(1):60. PubMed ID: 38862718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Management of pruritus in patients with cholestatic liver disease].
    Kremer AE; Kraus MR
    MMW Fortschr Med; 2016 Jun; 158(12):64-7. PubMed ID: 27324009
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of oral naltrexone for severe pruritus due to cholestatic liver disease in children.
    Zellos A; Roy A; Schwarz KB
    J Pediatr Gastroenterol Nutr; 2010 Dec; 51(6):787-9. PubMed ID: 20948447
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of Chronic Hepatic Itch.
    Düll MM; Kremer AE
    Dermatol Clin; 2018 Jul; 36(3):293-300. PubMed ID: 29929600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pilot study with IBAT inhibitor A4250 for the treatment of cholestatic pruritus in primary biliary cholangitis.
    Al-Dury S; Wahlström A; Wahlin S; Langedijk J; Elferink RO; Ståhlman M; Marschall HU
    Sci Rep; 2018 Apr; 8(1):6658. PubMed ID: 29704003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of the Patient- and Observer-Reported PRUCISION Instruments to Assess Pruritus and Sleep Disturbance in Pediatric Patients with Cholestatic Liver Diseases.
    Gwaltney C; Bean S; Venerus M; Karlsson L; Warholic N; Kjems L; Horn P
    Adv Ther; 2022 Nov; 39(11):5126-5143. PubMed ID: 36066744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions.
    Kremer AE; van Dijk R; Leckie P; Schaap FG; Kuiper EM; Mettang T; Reiners KS; Raap U; van Buuren HR; van Erpecum KJ; Davies NA; Rust C; Engert A; Jalan R; Oude Elferink RP; Beuers U
    Hepatology; 2012 Oct; 56(4):1391-400. PubMed ID: 22473838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in pathogenesis and treatment of pruritus.
    Bolier R; Oude Elferink RP; Beuers U
    Clin Liver Dis; 2013 May; 17(2):319-29. PubMed ID: 23540505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of butorphanol on morphine-induced itch and analgesia in primates.
    Lee H; Naughton NN; Woods JH; Ko MC
    Anesthesiology; 2007 Sep; 107(3):478-85. PubMed ID: 17721251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological interventions for pruritus in adult palliative care patients.
    Xander C; Meerpohl JJ; Galandi D; Buroh S; Schwarzer G; Antes G; Becker G
    Cochrane Database Syst Rev; 2013 Jun; (6):CD008320. PubMed ID: 23749733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study.
    Baumann U; Sturm E; Lacaille F; Gonzalès E; Arnell H; Fischler B; Jørgensen MH; Thompson RJ; Mattsson JP; Ekelund M; Lindström E; Gillberg PG; Torfgård K; Soni PN
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101751. PubMed ID: 34182185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pruritus in cholestasis: facts and fiction.
    Beuers U; Kremer AE; Bolier R; Elferink RP
    Hepatology; 2014 Jul; 60(1):399-407. PubMed ID: 24807046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pruritus in chronic cholestatic liver disease.
    Bunchorntavakul C; Reddy KR
    Clin Liver Dis; 2012 May; 16(2):331-46. PubMed ID: 22541702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.